Source numbers link to evidence. [Inference] marks analytical judgment, including motion classifications and causal explanations. Public evidence does not establish every internal decision or metric.
Conceptual illustration of a clinical symbol, protective boundary, and certification document, framing assessment as a specialized subject without implying approval, conformity, or patient safety.
- Company
- Scarlet · Medical-device certification · scarlet.cc
- Conversion motions
- [Inference] This research classifies Scarlet as Human Led.
- Scarlet beachhead and target customer
- [Inference] Developers of software and AI medical devices needing conformity assessment.
- Product and buying complexity
- [Inference] Technical documentation, quality systems and authorized assessment create a complex service purchase.
- Market at entry
- [Unverified] This focused brief does not establish the full market conditions at first sale.
- Evidence
- Evidence brief · 1 linked source · research date · method and limitations
The ten-step Revenue Engine reading map
These links locate relevant evidence. A linked section does not imply every detail of the step is publicly established.
- Acquire Your First Customers: Founder Led Sales Read first customers
- Embrace GTM Experimentation Read experiments & lessons
- Understand Your GTM Motion Options Read GTM motion
- Pick Your GTM Motion Not established in this entry
- Generate a Lead Read GTM motion · Read experiments & lessons
- Turn Leads into Paying Customers Read GTM motion
- Retain and Grow Your Customers Read retain & expand
- Build Your GTM Team Not established in this entry
- Plan Your Tech Stack Read experiments & lessons
- Optimize and Scale Through Metrics Not established in this entry
Scarlet: Origin and evidence boundary
The first paid customer and founder closing sequence were not established in this focused evidence brief.
Entrepreneurs First identifies Scarlet as founded in 2021 by James Dewar and Jamie Cox, serving software and AI medical-device certification. It describes Dewar’s computer-science and machine-learning training and both founders’ Babylon Health experience. This source establishes specialization and founder capabilities, not a full sales history. [1]
[1]Scarlet: Motion and buyer logic
[Inference] Developers of software and AI medical devices needing conformity assessment.
[Inference] Technical documentation, quality systems and authorized assessment create a complex service purchase.
[1]Scarlet: Retention and expansion hypothesis
[Inference] Repeated assessments and product updates can sustain a relationship, subject to independent review requirements.
[Unverified] Individual CSM ownership, enablement conversion and renewal cohorts were not established in this brief.
Scarlet: Critical reading
[Inference] Speed is valuable only alongside credible assessment. Certification outcomes must remain separate from commercial expansion incentives.
[Unverified] The inspected material does not establish failed-channel experiments or a complete causal account of growth.
Scarlet economics at a glance: Pricing is only half the story.
Exact current pricing was not verified in this brief.
[Inference] Repeated assessments and product updates can sustain a relationship, subject to independent review requirements.
[Inference] Speed is valuable only alongside credible assessment. Certification outcomes must remain separate from commercial expansion incentives.
Not publicly verified in this brief.
Not publicly verified in this brief.
The people in the Scarlet GTM story: People & capabilities.
James Dewar
People identified in the sourceJames Dewar — CEO, Goldsmiths computer science and Imperial machine learning; Jamie Cox — CTO, medical/software background.
See the source-backed account above; additional skills and training are not inferred as fact.
[1]Scarlet GTM: critical reading and analysis: Why it worked.
Where it breaks.
What worked—and why
[Inference] Speed is valuable only alongside credible assessment. Certification outcomes must remain separate from commercial expansion incentives.
What did not work
No substantiated failed experiment established in the inspected evidence.
What could have been better
[Inference] Validate the proposed growth mechanism with paid conversion, implementation cost and retained customer outcomes.
What another founder can use
[Inference] Repeated assessments and product updates can sustain a relationship, subject to independent review requirements.
Scarlet go-to-market FAQ: The questions that matter.
What does this case establish about Scarlet?
The inspected source supports the specific product, people or distribution facts in the origin section; a full chronological reconstruction remains incomplete. [1]
Is the full GTM history of Scarlet verified?
No. This is a focused evidence brief. The page distinguishes inspected claims from analytical hypotheses and lists the remaining gaps.
Which go-to-market motions is Scarlet classified under?
[Inference] This research classifies Scarlet as Human Led. Motion labels describe routes across segments and periods, not measured revenue shares.
Scarlet sources and open questions: Follow the sources.
- Entrepreneurs First — inspected company evidence Entrepreneurs First · primary
Origin, product, team or current commercial route described in the source; narrower claims are attributed in the text.
What remains unverified
Evidence brief rather than a full historical GTM reconstruction.
First contracts, complete hiring sequence, pricing history, CAC and retention require further source verification.
No historical website screenshot or named account expansion is represented as verified.
No verified visual capture is attached to this entry. A current screenshot is not a substitute for a historical capture.
